Helion Biotech

Helion Biotech is a company that engages in the restoration of an inherited immune defect by replacement therapy with recombinant human mannan-binding lectin (rhMBL). It focuses on MBL, a key component of the innate immune defence that is responsible for activation of the complement system upon binding to carbohydrate structures present on bacteria, viruses, and fungi.